Lanean...
Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
Patients with metastatic and recurrent osteosarcoma fare poorly, and new therapeutic strategies are needed to improve survival. Several recent complementary genomic and pathway analyses of both murine and human osteosarcoma have revealed common aberrations of the phosphoinositide 3-kinase (PI3K)/mam...
Gorde:
| Argitaratua izan da: | F1000Res |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
F1000Research
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4937817/ https://ncbi.nlm.nih.gov/pubmed/27441088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.8228.1 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|